Cargando…
Pure redox-sensitive paclitaxel–maleimide prodrug nanoparticles: Endogenous albumin-induced size switching and improved antitumor efficiency
A commercial albumin-bound paclitaxel nano-formulation has been considered a gold standard against breast cancer. However, its application still restricted unfavorable pharmacokinetics and the immunogenicity of exogenous albumin carrier. Herein, we report an albumin-bound tumor redox-responsive pacl...
Autores principales: | Lou, Xinyu, Zhang, Dong, Ling, Hao, He, Zhonggui, Sun, Jin, Sun, Mengchi, Liu, Dongchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343193/ https://www.ncbi.nlm.nih.gov/pubmed/34386337 http://dx.doi.org/10.1016/j.apsb.2020.12.001 |
Ejemplares similares
-
Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy
por: Yang, Jincheng, et al.
Publicado: (2018) -
Probing the fluorination effect on the self-assembly characteristics, in vivo fate and antitumor efficacy of paclitaxel prodrug nanoassemblies
por: Wang, Xin, et al.
Publicado: (2021) -
Self-delivering prodrug-nanoassemblies fabricated by disulfide bond bridged oleate prodrug of docetaxel for breast cancer therapy
por: Zhang, Shenwu, et al.
Publicado: (2017) -
Redox-Responsive Disulfide Bond-Bridged mPEG-PBLA Prodrug Micelles for Enhanced Paclitaxel Biosafety and Antitumor Efficacy
por: Chang, Sheng, et al.
Publicado: (2019) -
Bacteria-Mediated Synergistic Cancer Therapy: Small Microbiome Has a Big Hope
por: Lou, Xinyu, et al.
Publicado: (2021)